Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title | FOA | Organization | Release Date | Expire Date | Purpose |
|---|---|---|---|---|---|
| Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) | PAR-19-325 | NCI | The purpose of this Funding Opportunity Announcement (FOA) is to support collaborative research projects designed to address adverse sequelae of cancer therapies that persist and become chronic… More | ||
| Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) | PAR-19-276 | NCI | This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and… More | ||
| NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required) | PAR-21-299 | NCI | The purpose of the NCI Mentored Clinical Scientist Career Development Award (K08) program is to prepare individuals for careers that have a significant impact on the health-related research needs of… More | ||
| Notice of Request for Information to Better Facilitate Cancer Systems Epidemiology Research | NOT-CA-19-019 | NCI | N/A | Notice Request Information Better Facilitate Cancer Systems Epidemiology Research Notice Number: NOT-CA-19-019 Key Dates Release Date: January 28, 2019 Response Date: April 30 , 2019 Related… More | |
| Notice of Correction to Award Information in RFA-CA-19-040 "Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | NOT-CA-19-044 | NCI | N/A | Notice Correction Award Information RFA-CA-19-040 Advanced Development Informatics Technologies Cancer Research Management U24 Clinical Trial Optional) Notice Number: NOT-CA-19-044 Key Dates Release… More | |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) | RFA-CA-21-003 | NCI | This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel… More | ||
| Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) | PAR-21-322 | NCI | This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health… More | ||
| Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional) | RFA-CA-21-019 | NCI | The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U24 resource-related… More | ||
| Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) | RFA-CA-20-046 | NCI | Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to advance our understanding of: the modes of transmission of Kaposi sarcoma-associated herpesvirus (… More | ||
| Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed) | PAR-20-284 | NCI | This Funding Opportunity Announcement (FOA) entitled "Innovative Research in Cancer Nanotechnology (IRCN)" encourages applications promoting transformative discoveries in cancer biology and… More |